002407 多氟多
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入6,728,836-2.75%8,206,94811,937,56512,358,0067,808,856
减:营业总成本6,802,769-3.51%8,485,63311,262,8329,878,8296,187,791
    其中:营业成本5,969,648-6.06%7,484,25710,026,1278,585,9655,299,406
               财务费用32,267-1,513.15%25,80616,77160,374119,874
               资产减值损失(10,282)-73.97%(366,044)(59,027)(16,942)(79,580)
公允价值变动收益1,753-214.37%(1,372)(1,006)287124
投资收益31,503141.96%6,108(6,205)101,1101,551
    其中:对联营企业和合营企业的投资收益(4,748)392.55%(8,132)11,594(1,562)(1,748)
营业利润55,694-34.05%(388,806)633,8602,262,2301,409,363
利润总额99,046-8.14%(364,852)626,2062,281,0341,411,246
减:所得税费用34,115-63.31%122,631(16,111)258,291149,061
净利润64,931337.07%(487,482)642,3172,022,7431,262,185
减:非控股权益(13,124)2,439.07%(178,996)131,26174,6782,478
股东净利润78,055407.74%(308,487)511,0561,948,0651,259,707

市场价值指针
每股收益 (元) *0.067418.46%-0.2600.4601.8201.730
每股派息 (元) *----0.2000.3000.6000.500
每股净资产 (元) *6.948-6.76%7.1597.8038.4716.628
审计意见 #--标准的无保留意见标准无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容